187 related articles for article (PubMed ID: 32181759)
21. Testing for Hereditary Predisposition in Patients with Gynecologic Cancers, Quo Vadis?
Mitchell G; Schrader KA
Surg Pathol Clin; 2016 Jun; 9(2):301-6. PubMed ID: 27241110
[TBL] [Abstract][Full Text] [Related]
22. Genetic Testing: Challenges and Changes in Testing for Hereditary Cancer Syndromes.
King E; Mahon SM
Clin J Oncol Nurs; 2017 Oct; 21(5):589-598. PubMed ID: 28945723
[TBL] [Abstract][Full Text] [Related]
23. Hereditary cancer testing challenges: assembling the analytical pieces to solve the patient clinical puzzle.
Bowles KR; Mancini-DiNardo D; Coffee B; Cox HC; Qian Y; Elias M; Singh N; Judkins T; Leclair B; Roa BB
Future Oncol; 2019 Jan; 15(1):65-79. PubMed ID: 30113232
[TBL] [Abstract][Full Text] [Related]
24. Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.
Soukupova J; Zemankova P; Lhotova K; Janatova M; Borecka M; Stolarova L; Lhota F; Foretova L; Machackova E; Stranecky V; Tavandzis S; Kleiblova P; Vocka M; Hartmannova H; Hodanova K; Kmoch S; Kleibl Z
PLoS One; 2018; 13(4):e0195761. PubMed ID: 29649263
[TBL] [Abstract][Full Text] [Related]
25. A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients.
Lincoln SE; Kobayashi Y; Anderson MJ; Yang S; Desmond AJ; Mills MA; Nilsen GB; Jacobs KB; Monzon FA; Kurian AW; Ford JM; Ellisen LW
J Mol Diagn; 2015 Sep; 17(5):533-44. PubMed ID: 26207792
[TBL] [Abstract][Full Text] [Related]
26. Genetic testing and prevention of hereditary cancer at the MMCI--over 10 years of experience.
Foretova L; Petrakova K; Palacova M; Kalabova R; Svoboda M; Navratilova M; Schneiderova M; Bolcak K; Krejci E; Drazan L; Mikova M; Hazova J; Vasickova P; Machackova E
Klin Onkol; 2010; 23(6):388-400. PubMed ID: 21348412
[TBL] [Abstract][Full Text] [Related]
27. Evolving Significance of Tumor-Normal Sequencing in Cancer Care.
Mandelker D; Ceyhan-Birsoy O
Trends Cancer; 2020 Jan; 6(1):31-39. PubMed ID: 31952779
[TBL] [Abstract][Full Text] [Related]
28. Co-occurrence of Lynch syndrome and juvenile polyposis syndrome confirmed by multigene panel testing.
Silva-Smith R; Sussman DA
Fam Cancer; 2018 Jan; 17(1):87-90. PubMed ID: 28600700
[TBL] [Abstract][Full Text] [Related]
29. The Next Generation of Molecular Pathology is Here: Validation of Next-Generation Sequencing Technology for Clinical Molecular Testing Across Multiple Different Disciplines.
Weck KE
Arch Pathol Lab Med; 2017 Jun; 141(6):749-750. PubMed ID: 28557596
[No Abstract] [Full Text] [Related]
30. The future of DNA diagnostics.
Skolnick MH
Dis Markers; 1999 Oct; 15(1-3):106-7. PubMed ID: 10595260
[No Abstract] [Full Text] [Related]
31. Inherited kidney cancer syndromes.
Ball MW; Shuch BM
Curr Opin Urol; 2019 Jul; 29(4):334-343. PubMed ID: 31083011
[TBL] [Abstract][Full Text] [Related]
32. Hereditary colorectal cancer syndromes and genetic testing.
Macaron C; Leach BH; Burke CA
J Surg Oncol; 2015 Jan; 111(1):103-11. PubMed ID: 24975382
[TBL] [Abstract][Full Text] [Related]
33. Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test.
Nguyen KA; Syed JS; Espenschied CR; LaDuca H; Bhagat AM; Suarez-Sarmiento A; O'Rourke TK; Brierley KL; Hofstatter EW; Shuch B
Cancer; 2017 Nov; 123(22):4363-4371. PubMed ID: 28787086
[TBL] [Abstract][Full Text] [Related]
34. [Genetic diagnosis of cancers? Which cancers should be screened?].
Chompret A
Ann Med Interne (Paris); 2001 Jun; 152(4):249-61. PubMed ID: 11474373
[TBL] [Abstract][Full Text] [Related]
35. Common hereditary cancer syndromes.
Greco KE; Mahon S
Semin Oncol Nurs; 2004 Aug; 20(3):164-77. PubMed ID: 15491026
[TBL] [Abstract][Full Text] [Related]
36. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
[TBL] [Abstract][Full Text] [Related]
37. Contribution of Inherited Variants to Hereditary Cancer Syndrome Predisposition.
Güleç Ceylan G; Arslan Satılmış SB; Çavdarlı B; Semerci Gündüz CN
Tohoku J Exp Med; 2022 Nov; 258(4):319-325. PubMed ID: 36288950
[TBL] [Abstract][Full Text] [Related]
38. [Rare tumors as leading symptom of hereditary tumor syndromes].
Perne C; Steinke-Lange V; Aretz S; Spier I
Pathologe; 2020 Sep; 41(5):535-549. PubMed ID: 32780213
[TBL] [Abstract][Full Text] [Related]
39. Rapid detection of germline mutations for hereditary gastrointestinal polyposis/cancers using HaloPlex target enrichment and high-throughput sequencing technologies.
Kohda M; Kumamoto K; Eguchi H; Hirata T; Tada Y; Tanakaya K; Akagi K; Takenoshita S; Iwama T; Ishida H; Okazaki Y
Fam Cancer; 2016 Oct; 15(4):553-62. PubMed ID: 26837502
[TBL] [Abstract][Full Text] [Related]
40. Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.
LaDuca H; Stuenkel AJ; Dolinsky JS; Keiles S; Tandy S; Pesaran T; Chen E; Gau CL; Palmaer E; Shoaepour K; Shah D; Speare V; Gandomi S; Chao E
Genet Med; 2014 Nov; 16(11):830-7. PubMed ID: 24763289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
